Searched for
INDIA FINANCIAL REGULATORS
Manipal Hospitals is said to plan $1 billion IPO in JulyManipal Health Enterprises is likely to launch its IPO as early as next month, targeting a valuation of around $10 billion. Backed by Temas...- NRE vs NRO: One account can make your interest tax-free, the other can attract over 30% TDSNRIs and OCIs can use NRE accounts for overseas income and NRO accounts for India-sourced income, but tax treatment differs sharply. NRE in...
- Prime Focus shares hit 5% upper circuit as Sebi halts proceedings in misleading financials casePrime Focus shares were locked in 5% upper circuit after Sebi closed its investigation. The market regulator found the company used correct...
- Stocks in news: Prime Focus, Groww, GIC RE, Wipro, NykaaIndian benchmark indices traded with a positive bias, with the Nifty consolidating near the 24,000 mark and closing near its day's high. Se...
- Foreign investors may bet big on Indian stocks after regulatory clarity emergesIndia has opened its stock markets to direct investment by foreign individuals, aiming to broaden capital sources beyond FPIs. While a long...
- Banks, fintechs join forces to fight money laundering, terror financing under new platformIndia's financial sector has launched a new platform called ARIFAC. This brings together banks, NBFCs, payment firms, insurers, and other e...
- CCI clears TVS Group's acquisition of PGIM India AMC, Temasek-Romsons dealIndia's fair trade regulator CCI has given the green light for TVS Group entities to acquire PGIM India Asset Management. The regulator als...
- NCDEX launches 'Har Ghar Investor' campaignNCDEX Ltd has launched its nationwide 'HarGhar Investor' campaign in Guwahati, aiming to bring every Indian household into formal, regulate...
- Sebi drops proceedings against Prime Focus in misleading financials caseSebi has closed adjudication proceedings against Prime Focus and its directors, ruling that the company correctly accounted for business tr...
- CCI approves Kedaara Capital's Rs 750 crore stake purchase proposal in Axis FinanceIndia's competition watchdog has given the green light for Kedaara Capital to invest Rs 750 crore in Axis Finance. This marks a significant...
- India's digital fraud rate nearly double global average as scammers target existing accountsIndia's digital fraud rate in 2025 reached 7.1%, almost double the global average. This indicates growing online fraud risks as digital pay...
- HCL Tech shares jump 3% after buying stake in Sarvam AI for Rs 1,427 croreHCL Tech share price gained 3% after i invested $150 million in Sarvam AI, India's largest AI startup, acquiring a 10.46% stake. This strat...
- RBI puts curbs on banks' sale of third-party productsThe Reserve Bank of India has prohibited third-party incentives to employees of regulated entities, while allowing banks and NBFCs to rewar...
- RBI releases final guidelines on marketing, sales incentives of financial productsRBI has prohibited third-party incentives to employees of regulated entities for selling financial products, while allowing banks and NBFCs...
- Nilesh Shah bats for minimum qualifying criteria for F&O trading after Maharashtra man kills family, self over Rs 1.8 cr lossFollowing a tragic incident in Maharashtra linked to stock market losses, Kotak AMC's Nilesh Shah called for mandatory qualification criter...
- Residents tempted to gatecrash FCNR party for NRIsWealthy Indians are finding ways to benefit from a new foreign currency deposit scheme. They are sending money to NRI relatives as gifts to...
- Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s whyDabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...
- Japanese investors are looking beyond China... India is key alternative: Tsutomu Takemura, Senior MD, NomuraIndia is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...
- US drug regulator issues import alert for drugs made at a Dabur India plantThe US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...
- RBI says fully prepared for 'Mythos' cyber threat; advisories issued to regulated entitiesThe Reserve Bank of India is ready for cyber threats from the Mythos platform. Advisories have been sent to financial entities. The RBI is ...
Load More
